Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
07/29/2004 | US20040146888 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
07/29/2004 | US20040146872 Comprises nucleotide sequences coding delta-2-enoyl-coA isomerase for use in identifying modulators for treatment and diagnosis of inflammatory, cardiovascular, skin, body weight and cancer disorders |
07/29/2004 | US20040146549 Amino acid sequences capable of facilitating penetration across a biological barrier |
07/29/2004 | CA2516398A1 Method of modulating il-6 |
07/29/2004 | CA2512271A1 Network-assisted global positioning systems, methods and terminals including doppler shift and code phase estimates |
07/29/2004 | CA2511858A1 Metastin derivative and use thereof |
07/28/2004 | EP1440084A2 Sperm factor sequences |
07/28/2004 | EP1440076A1 Silicon compounds |
07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
07/28/2004 | EP1440059A1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
07/28/2004 | EP1440052A1 Benzamide derivatives as antagonists of orexin receptors |
07/28/2004 | EP1439845A1 Inactivation of papillomavirus |
07/28/2004 | EP1439841A2 Androgen receptor modulators and methods of use thereof |
07/28/2004 | EP1439837A1 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
07/28/2004 | EP1439834A1 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
07/28/2004 | EP1439831A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect |
07/28/2004 | EP1322593B1 O-substituted 6-methyl-tramadol derivatives |
07/28/2004 | EP1322592B1 Substituted 1-aminobutan-3-ol derivatives |
07/28/2004 | EP1220667B1 Beta-agonists for treating endometriosis or infertility, or improving fertility |
07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
07/28/2004 | CN1516739A Use of HMG fragments as anti-inflammatory agents |
07/28/2004 | CN1516701A (Pyrido/thieno)-[f]-oxazepin-5-one derivatives as AMPA receptor positive regulator |
07/28/2004 | CN1516699A Polymorphic forms of 1-4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl) piperazine hydrochloride |
07/28/2004 | CN1516698A Arylindenopyridines with PDE inhibiting activity |
07/28/2004 | CN1516693A Benzimidazoles that are useful in treating sexual dysfunction |
07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
07/28/2004 | CN1516580A Sulfonamides |
07/28/2004 | CN1515588A Biological function of human testis specific gene HSD-3,8 coded protein |
07/28/2004 | CN1515562A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
07/28/2004 | CN1515559A Phenyl-and aminophenyl-alkyl sulfonamide and urea derivative |
07/28/2004 | CN1515524A Method for extracting isoflavone, flavones and lactone from armenica sibirica leaf by adoptnig solvent method |
07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
07/28/2004 | CN1515307A Medicine for curing hysteromyoma |
07/28/2004 | CN1515305A Compound powder peparation for curing gynecopathy, its preparation method and application |
07/28/2004 | CN1515297A New application of epimedium |
07/28/2004 | CN1515290A Capsule for curing hyperplasia of mammary glands and its preparation method |
07/28/2004 | CN1515279A Chinese medicine suppository for curing gynecopathy, and its preparing method and use method |
07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
07/28/2004 | CN1515250A New houttuynin sodium injection preparation and its preparation method |
07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
07/28/2004 | CN1159338C LHRH tandem repeat peptide and vaccine and immunogenic composition |
07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
07/28/2004 | CN1159056C Medicine for treating mastropathy by exteriorly applying to acupoints |
07/28/2004 | CN1159033C Chinese medicine composition for gynopathy |
07/28/2004 | CN1159011C 苦参碱阴道凝胶 Matrine vaginal gel |
07/27/2004 | US6767916 Chalcone coumarins |
07/27/2004 | US6767915 Substituted piperidines as melanocortin receptor agonists |
07/27/2004 | US6767902 Androgen as a male contraceptive and non-contraceptive androgen replacement |
07/27/2004 | US6767736 Human ion channel protein and polynucleotides encoding the same |
07/27/2004 | US6767326 Methods for delivering a drug to a patient while preventing the exposure of a foetus or other contraindicated individual to the drug |
07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
07/22/2004 | WO2004060893A1 Pyrrolopyridine potassium channel openers |
07/22/2004 | WO2003087086A3 Substituted indoles |
07/22/2004 | WO2003070675A3 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
07/22/2004 | WO2003059293A3 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
07/22/2004 | US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required |
07/22/2004 | US20040143014 Therapeutic use of alpha-2-delta ligands |
07/22/2004 | US20040143010 Synergistic mixture with phosphodiesterase inhibitor; control concentration of cyclic guanosine monophosphate in penis |
07/22/2004 | US20040143003 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
07/22/2004 | US20040142944 Compositions for nasal application |
07/22/2004 | US20040142935 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor liqands and/or serotonergic ligands |
07/22/2004 | US20040142932 treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase activity |
07/22/2004 | US20040142877 Ligands of the $g(a)v$g(b)6 integrin |
07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
07/22/2004 | US20040141966 Inhibition of leukocyte adhesion |
07/22/2004 | US20040141958 cytotoxic T-cell mediated killing of disease cells that express a weakly immunogenic or non-immunogenic cell-associated polypeptide antigen in an animal by administering a cytotoxic T-cell epitope and a T-helper lymphocyte |
07/21/2004 | EP1439190A1 Growth differentiation factor-5 |
07/21/2004 | EP1439187A1 O2-Arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1- (2-carboxylato)pyrrolidin-1-yl diazen-1-ium-1,2-diolates |
07/21/2004 | EP1438973A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
07/21/2004 | EP1438336A2 Compositions of fsh with high sialylation degree and their use for the preparation of medicinaments |
07/21/2004 | EP1438307A2 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist |
07/21/2004 | EP1438295A2 Azole derivatives and pharmaceutical compositions containing them |
07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
07/21/2004 | EP1438289A1 Indole derivatives as cox ii inhibitors |
07/21/2004 | EP1438104A1 Co-cycloalkyl 17-heteroaryl prostaglandin e2 analogs as ep2-receptor agonists |
07/21/2004 | EP1438048A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
07/21/2004 | EP1438041A2 Spermicides |
07/21/2004 | EP1320521B1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(en)oic acid as therapeutic agents |
07/21/2004 | EP0956024B1 Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen |
07/21/2004 | CN1514843A Somatostatin-dopamine chimeric analogs |
07/21/2004 | CN1514835A Benzoxazepine derivatives and their use as AMPA receptor stimulators |
07/21/2004 | CN1514732A Pharmaceutical formulation consisting of plant extract with calcium coating |
07/21/2004 | CN1513844A New Carboxglic acid derivative, its preparation and application |
07/21/2004 | CN1513513A Chinese animal medicine for treating mammitis and its preparation method |
07/21/2004 | CN1513484A Traditional chinese medicine for treating postpartum diseases |
07/21/2004 | CN1513452A Use of CGMP phosphodiesterase inhibitor for treating sexual impotence |
07/21/2004 | CN1513446A Injection of sodium bouttuynin, and its prepn. method |
07/21/2004 | CN1158297C Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
07/21/2004 | CN1158290C Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
07/21/2004 | CN1158206C Hormone replacement therapy method and hormone dispenser |
07/21/2004 | CN1158104C Chinese medicine preparation for treating acute condyloma |
07/21/2004 | CN1158087C Process for preparing capsule to treat ganopathy |
07/20/2004 | US6765013 Thiazolidinedione derivatives for the treatment of diabetes and other diseases |
07/20/2004 | US6765011 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
07/20/2004 | CA2254731C Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids |
07/15/2004 | WO2004058969A1 Preventives/remedies for cancer |